{"title":"溴己新阻断丝氨酸蛋白酶(TMPRSS2);探讨预防新冠肺炎感染的潜在治疗方法","authors":"R. Tolouian, Audrey Tolouian, M. Ardalan","doi":"10.33470/2379-9536.1286","DOIUrl":null,"url":null,"abstract":"Coronaviruses have caused at least three large scale epidemics/pandemics in humans over the past twenty years – severe acute respiratory syndrome (SARS) in 2003; the Middle East respiratory syndrome (MERS) in 2012; novel coronavirus disease (COVID-19) in 2019 – taking many lives all over the world. World Health Organization (WHO) named the new virus responsible for COVID-19 as SARS-CoV-2.","PeriodicalId":93035,"journal":{"name":"Marshall journal of medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection\",\"authors\":\"R. Tolouian, Audrey Tolouian, M. Ardalan\",\"doi\":\"10.33470/2379-9536.1286\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Coronaviruses have caused at least three large scale epidemics/pandemics in humans over the past twenty years – severe acute respiratory syndrome (SARS) in 2003; the Middle East respiratory syndrome (MERS) in 2012; novel coronavirus disease (COVID-19) in 2019 – taking many lives all over the world. World Health Organization (WHO) named the new virus responsible for COVID-19 as SARS-CoV-2.\",\"PeriodicalId\":93035,\"journal\":{\"name\":\"Marshall journal of medicine\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Marshall journal of medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33470/2379-9536.1286\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marshall journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33470/2379-9536.1286","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection
Coronaviruses have caused at least three large scale epidemics/pandemics in humans over the past twenty years – severe acute respiratory syndrome (SARS) in 2003; the Middle East respiratory syndrome (MERS) in 2012; novel coronavirus disease (COVID-19) in 2019 – taking many lives all over the world. World Health Organization (WHO) named the new virus responsible for COVID-19 as SARS-CoV-2.